Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

24.85 -0.01 (-0.04%)
Streaming Delayed Price Updated: 9:56 AM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences Inc

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Here's Why Cassava Sciences Is Up 1,152% in the First Half of 2021
This small-cap biotech has shot up in value as the company's Alzheimer's drug makes it way through clinical trials. 
Via The Motley Fool
Is Now The Time To Buy Stock In Cassava Sciences, Facebook Or Apple?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
Why Is Cassava Sciences Stock Soaring in 2021?
The stock market is excited by the clinical trial results for its Alzheimer's drug. 
Via The Motley Fool
10 Biggest Price Target Changes For Tuesday
Citigroup boosted International Business Machines Corporation (NYSE: 
Via Benzinga
Building A Bear-Proof Portfolio
How to invest confidently as the Fear & Greed gauge hits early 2020 fear levels. 
Via Talk Markets
Why Cassava Sciences Stock Soared Today
Investors applauded the company's update on its clinical programs. 
Via The Motley Fool
Why Cassava Sciences Shares Are Moving Today
Cassava Sciences Inc (NASDAQ:SAVA) shares are trading high... 
Via Benzinga
Understanding Cassava Sciences's Unusual Options Activity
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Friday. The stock price moved down to $79.73 following the option alert. Sentiment: BEARISH Option... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Cassava Sciences Stock Moved Higher Monday
The biotech stock bounced back big Monday after tumbling on Friday. 
Via The Motley Fool
38 Stocks Moving In Monday's Mid-Day Session
Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in... 
Via Benzinga
24 Stocks Moving in Monday's Pre-Market Session
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)... 
Via Benzinga
Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval. 
Via Investor's Business Daily
Exposures Product Safety
64 Biggest Movers From Friday
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Follow the Money to Find Out What's Working This Year
The notorious dip-buyers have been aggressively supporting this market ever since the pandemic low point last year. If they become fully invested, the flow of new money into the market could stop. 
Via Talk Markets
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ... 
Via Benzinga
This Biotech Stock Is Beating GameStop
Now the question is whether the gains are here to stay. 
Via The Motley Fool
Is It Too Late to Buy Cassava Sciences Stock?
Just because the stock has had a massive run doesn't mean its biggest gains are behind it. 
Via The Motley Fool
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... 
Via Benzinga
Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
Via FinancialNewsMedia
Topics Death
Exposures Death
Could Cassava Sciences Be a Millionaire-Maker Stock?
Can this biotech underdog develop an Alzheimer's drug investors can count on? 
Via The Motley Fool
44 Biggest Movers From Yesterday
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume... 
Via Benzinga
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a... 
Via Benzinga
Cassava Sciences Stock Gains After Outlining Clinical Development Progress For Lead Alzheimer's Candidate
Cassava Sciences Inc (NASDAQ: SAVA) has announced a mid-year update highlighting clinical development progress and providing guidance on upcoming data releases for... 
Via Benzinga
These 2 Biotech Stocks Are Up 1,000% This Year
New approaches to treating Alzheimer's could mean even bigger gains in the future. 
Via The Motley Fool
Why Anavex Stock Nearly Round-Tripped Its Double-Digit Gain This Week
Researchers featured a pair of Anavex Life Sciences drugs in a paper on Alzheimer's disease this week, but AVXL stock plunged on Tuesday. 
Via Investor's Business Daily
Where Will Biogen Be in 1 Year?
The controversy never ends with this biotech's new Alzheimer's drug. 
Via The Motley Fool
Exposures Product Safety
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.